BioSpace News Archive

Spin-out Completed and DTC Eligibility Received; SERFOR Permit is Expected Shortly; Advisory Board Expanded; Rights Offering Underway

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company”), a medical device company commercializing IzoView, a 360-degree computed tomography (CT) imaging system designed for breast imaging and cancer diagnosis, announced that it is modifying its U.S.

Nexcella, Inc., a subsidiary of Immix Biopharma, Inc., announced that effective , Jeffrey H. Cooper, former Chief Financial Officer of BioMarin Pharmaceutical Inc., has been appointed to the Company’s Board of Directors.

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and the University of Oxford today announced that results from the SYMPLIFY study have been published in The Lancet Oncology.

The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of subcutaneous (SC) Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc),for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

Sequantrix GmbH, a biotech start-up on a mission to unlock novel antifibrotic therapies, announced the launch of its operations.

Simulations Plus, Inc. today announced the acquisition of Immunetrics, Inc. (“Immunetrics”), a modeling and simulation company focused on accelerating drug development in oncology, immunology, and autoimmune diseases.

Axena Health, Inc., a FemTech medical device company focused on scalable treatments for female pelvic health, introduced the Leva® Pelvic Health System for the first-line treatment of chronic fecal incontinence, also called accidental bowel leakage, in women.

Marius Pharmaceuticals announced today its sponsorship of the AXYS 2023 Virtual Family Conference.

PaxMedica, Inc. announced that its CEO, Howard Weisman, participated in a webcast on Saturday, June 17th, hosted by The BRAIN Foundation.